Danaparoid cross-reactivity with heparin-induced thrombocytopenia antibodies: report of 12 cases

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Intensive Care Medicine

• Publication date

  2009-04-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00134-009-1464-xPMID 19350215
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Incidence and features of heparin-induced thrombocytopenia (HIT) in burn patients: A retrospective study

  2008cited by this paper
• Physicians Evidence-Based Clinical Practice Development : American College of Chest Thrombolytic Therapy Guideline Methodology for Antithrombotic and

  2008cited by this paper
• Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

  2008cited by this paper
• Heparin-induced thrombocytopenia in intensive care patients

  2007cited by this paper
• Heparin-induced thrombocytopenia in the critical care setting: Diagnosis and managementˆ

  2006cited by this paper
• Sophorolipids in sepsis: antiinflammatory or antibacterial?

  2006cited by this paper
• Treatment of Heparin‐induced Thrombocytopenia: A Practical Argatroban Dosing Protocol for Nurses

  2006cited by this paper
• Heparin-induced thrombocytopenia (HIT)

  2006cited by this paper
• Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin.

  2006cited by this paper
• [Heparin induced thrombocytopenia].

  2003cited by this paper
• Heparin-induced thrombocytopenia and cardiac surgery.

  2003cited by this paper
• Heparin-induced thrombocytopenia and cardiac surgery.

  2003cited by this paper
• Heparin induced thrombocytopenia

  2003cited by this paper
• Heparin-induced thrombocytopenia-associated thrombosis in pediatric intensive care patients.

  2002cited by this paper
• Heparin-induced thrombocytopenia: a common complication in cardiac transplant recipients.

  2002cited by this paper
• A Comparison of Danaparoid and Lepirudin in Heparin-induced Thrombocytopenia

  2001cited by this paper
• Heparin‐induced thrombocytopenia and thrombosis syndrome: in vivo cross‐reactivity with danaparoid and successful treatment with r‐Hirudin

  2001cited by this paper
• Heparin‐induced thrombocytopenia (HIT): in vitro and in vivo cross‐reactivity to danaparoid sodium and successful treatment with recombinant hirudin (lepirudin)

  2000cited by this paper
• Efficacy and safety of danaparoid sodium (ORG 10172) in critically ill patients with heparin-associated thrombocytopenia.

  1999cited by this paper
• Heparin-induced Thrombocytopenia: IgG Binding to PF4-Heparin Complexes in the Fluid Phase and Cross-reactivity with Low Molecular Weight Heparin and Heparinoid

  1998cited by this paper
• Fatal Danaparoid-sodium Induced Thrombocytopenia and Arterial Thromboses

  1998cited by this paper
• Heparin-induced thrombocytopenia and thrombosis syndrome

  1997cited by this paper
• The Clinical Usefulness of the Platelet Aggregation Test for the Diagnosis of Heparin-Induced Thrombocytopenia

  1993cited by this paper
• Platelet Factor 4 Complexed to Heparin Is the Target for Antibodies Generated in Heparin-Induced Thrombocytopenia

  1992cited by this paper
• Orgaran in Heparin-lnduced Thrombocytopenia

  1992cited by this paper
• Orgaran in heparin-induced thrombocytopenia.

  1992cited by this paper
• Impairment of Phosphatidylinositol Metabolism in a Patient with a Bleeding Disorder Associated with Defects of Initial Platelet Responses

  1988cited by this paper
• A diagnostic test for heparin-induced thrombocytopenia.

  1986cited by this paper

• Treatment of Heparin-Induced Thrombocytopenia (HIT) With Fondaparinux in a Patient With Liver Dysfunction

  2025cites this paper
• Danaparoid failure in heparin-induced thrombocytopenia due to acquired antithrombin deficiency: A case report.

  2025cites this paper
• How to Ensure Patency of the Extracorporeal Circuit in Hemodialysis: Global Perspectives.

  2024cites this paper
• Danaparoid—Consensus Recommendations on Its Clinical Use

  2024cites this paper
• Physiopathologie, diagnostic biologique et traitement des thrombopénies induites par l’héparine

  2022cites this paper
• La thrombopénie induite par héparine : mise au point

  2021cites this paper
• Praxis der medikamentösen Thromboseprophylaxe und Antikoagulation bei Patienten mit Sepsis und vorbestehender Antikoagulation oder Heparin-induzierter Thrombozytopenie Typ II – Ergebnisse einer deutschlandweiten Umfrage auf Intensivstationen

  2021cites this paper
• [Heparin-induced thrombocytopenia: Update].

  2021cites this paper
• Venous Thromboembolism Prophylaxis in Intensive Care Units (Review)

  2020cites this paper
• Comparative Analysis of a French Prospective Series of 144 Patients with Heparin-Induced Thrombocytopenia (FRIGTIH) and the Literature

  2020cites this paper
• Diagnosis and management of heparin-induced thrombocytopenia.

  2020cites this paper
• Cross-Reactivity Between Heparin and Danaparoid Antibodies in Cardiac Surgery.

  2017cites this paper
• European guidelines on perioperative venous thromboembolism prophylaxis: Intensive care.

  2017cites this paper
• Données actualisées sur les thrombopénies induites par l’héparine

  2017cites this paper
• Persistent heparin-induced thrombocytopenia: danaparoid cross-reactivity or delayed-onset heparin-induced thrombocytopenia? A case report.

  2016cites this paper
• Dabigatran approaching the realm of heparin-induced thrombocytopenia

  2016cites this paper
• Heparin induced thrombocytopenia in critically ill: Diagnostic dilemmas and management conundrums.

  2015cites this paper
• 25 – Heparin-Induced Thrombocytopenia

  2013cites this paper
• Traitement anticoagulant initial de l’embolie pulmonaire

  2011cites this paper
• Heparin-induced thrombocytopenia in the ICU: an overview

  2011influential citation
• Heparin-induced thrombocytopenia: Successful biological and clinical management with lepirudin despite severe renal impairment

  2011cites this paper
• [Initial antithrombotic therapy for pulmonary embolism].

  2011cites this paper
• Year in review in Intensive Care Medicine 2009: II. Neurology, cardiovascular, experimental, pharmacology and sedation, communication and teaching

  2010cites this paper
• Drugs that affect blood coagulation, fibrinolysis, and hemostasis

  2010cites this paper